| Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion R Straussman, T Morikawa, K Shee, M Barzily-Rokni, ZR Qian, J Du, ... Nature 487 (7408), 500-504, 2012 | 1828 | 2012 |
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer Y Schlesinger, R Straussman, I Keshet, S Farkash, M Hecht, ... Nature genetics 39 (2), 232-236, 2007 | 1275 | 2007 |
| Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo, MS Lawrence, D Auclair, ... Cancer cell 25 (1), 91-101, 2014 | 1014 | 2014 |
| Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 931 | 2017 |
| The human tumor microbiome is composed of tumor type–specific intracellular bacteria D Nejman, I Livyatan, G Fuks, N Gavert, Y Zwang, LT Geller, ... Science 368 (6494), 973-980, 2020 | 749 | 2020 |
| Tumor microbiome diversity and composition influence pancreatic cancer outcomes E Riquelme, Y Zhang, L Zhang, M Montiel, M Zoltan, W Dong, P Quesada, ... Cell 178 (4), 795-806. e12, 2019 | 656 | 2019 |
| A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway InhibitorsMelanoma Cell State Affects Intrinsic MAPK Inhibitor Resistance DJ Konieczkowski, CM Johannessen, O Abudayyeh, JW Kim, ZA Cooper, ... Cancer discovery 4 (7), 816-827, 2014 | 493 | 2014 |
| Developmental programming of CpG island methylation profiles in the human genome R Straussman, D Nejman, D Roberts, I Steinfeld, B Blum, N Benvenisty, ... Nature structural & molecular biology 16 (5), 564-571, 2009 | 463 | 2009 |
| The microbiome and human cancer GD Sepich-Poore, L Zitvogel, R Straussman, J Hasty, JA Wargo, R Knight Science 371 (6536), eabc4552, 2021 | 284 | 2021 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 164 | 2021 |
| Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression L Parhi, T Alon-Maimon, A Sol, D Nejman, A Shhadeh, T Fainsod-Levi, ... Nature communications 11 (1), 3259, 2020 | 154 | 2020 |
| Identification of bacteria-derived HLA-bound peptides in melanoma S Kalaora, A Nagler, D Nejman, M Alon, C Barbolin, E Barnea, ... Nature 592 (7852), 138-143, 2021 | 110 | 2021 |
| Microbial exposure during early human development primes fetal immune cells A Mishra, GC Lai, LJ Yao, TT Aung, N Shental, A Rotter-Maskowitz, ... Cell 184 (13), 3394-3409. e20, 2021 | 109 | 2021 |
| Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome AA Kuperman, A Zimmerman, S Hamadia, O Ziv, V Gurevich, B Fichtman, ... BJOG: An International Journal of Obstetrics & Gynaecology 127 (2), 159-169, 2020 | 95 | 2020 |
| Microbiome and cancer N Cullin, CA Antunes, R Straussman, CK Stein-Thoeringer, E Elinav Cancer Cell 39 (10), 1317-1341, 2021 | 93 | 2021 |
| High-throughput screen identifies host and microbiota regulators of intestinal barrier function I Grosheva, D Zheng, M Levy, O Polansky, A Lichtenstein, O Golani, ... Gastroenterology 159 (5), 1807-1823, 2020 | 81 | 2020 |
| Kinking the coiled coil–negatively charged residues at the coiled-coil interface R Straussman, A Ben-Ya’acov, DN Woolfson, S Ravid Journal of molecular biology 366 (4), 1232-1242, 2007 | 71 | 2007 |
| A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014; 4: 816–827. doi: 10.1158/2159-8290 DJ Konieczkowski, CM Johannessen, O Abudayyeh, JW Kim, ZA Cooper, ... CD-13-0424.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 60 | |
| Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer K Shee, W Yang, JW Hinds, RA Hampsch, FS Varn, NA Traphagen, ... Journal of Experimental Medicine 215 (3), 895-910, 2018 | 55 | 2018 |
| Predicting and affecting response to cancer therapy based on pathway-level biomarkers R Ben-Hamo, A Jacob Berger, N Gavert, M Miller, G Pines, R Oren, ... Nature communications 11 (1), 3296, 2020 | 52 | 2020 |
